Lack of Trust Hindering AI Progress in Medical Settings: GE Healthcare Report

Date:

A recent survey from GE Healthcare has highlighted growing distrust around the use of artificial intelligence (AI) in medical settings. The Reimagining Better Health poll of 5,500 patients and patient advocates and 2,000 clinicians found that the benefits of AI in healthcare are understood, with 61% of clinicians agreeing that the technology can assist in decision-making. However, 55% of respondents said that AI was not ready for use in medicine and 58% expressed a lack of trust in AI data. The main reason for lack of trust is the potential for algorithms to produce discriminatory results due to biased data. The study also found that only 55% of surveyed clinicians feel they receive sufficient training on how to use medical technology. Clinicians need a better understanding of how AI works and how it can augment their work, the survey suggests. As healthcare systems face pressures, AI-driven systems could help eliminate administrative tasks, freeing up clinicians to focus on patient care.

See also  Elon Musk's xAI Open-Sources Grok Amid Feud

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.